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Abstract
Vibrio vulnificus (V. vulnificus), a Gram-negative marine bacterium, can cause life-threaten-
ing primary septicemia, especially in patients with liver diseases. How V. vulnificus affects
the liver and how it acts on macrophages are not well understood. In this report, we demon-
strated that V. vulnificus infection causes a strong inflammatory response, marked expan-
sion of liver-resident macrophages, and liver damage in mice. We demonstrated further that
V. vulnificus activates mTOR in macrophages and inhibition of mTOR differentially regulates
V. vulnificus induced inflammatory responses, suggesting the possibility of targeting mTOR
as a strategy to modulate V. vulnificus induced inflammatory responses.
Introduction
Vibrio vulnificus (V. vulnificus) is a halophilic, Gram-negative and life-threatening marine
bacterium [1, 2]. V. vulnificus infection can cause severe primary septicemia in patients with
liver diseases such as viral hepatitis, advanced cirrhosis, and chronic alcoholic liver disease [3].
Despite previous studies have significantly advanced our understanding of the pathogenesis
of V. vulnificus infection, mechanisms that regulate V. vulnificus-mediated responses remain
unclear.
Upon infection, innate immune cells sense the pathogen and initiate cascades of events
that result in the production of cytokines such as IL-1β, IL-6, and TNFα, which recruit other
immune cells such as macrophages, neutrophils, and dendritic cells (DCs) to defend against
pathogen invasion [4, 5]. Toll-like receptors (TLRs) or Nod-like receptors (NLRs) recognition of
bacterial components activates NF-κB signaling, which is important for transcription of many
cytokines [6]. In addition, activation of inflammasomes, marked by caspase-1 activation and IL-
1β secretion [7–10], is an important aspect of innate response to danger signals during bacterial
infection. Mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates
both adaptive and innate immune cell development, metabolism, and function [11–16]. mTOR
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forms two distinct signaling complexes, mTORC1 and mTORC2. Activated mTORC1 phosphor-
ylates multiple downstream molecules such as S6K1 and 4E-BP1. mTORC2 phosphorylates Akt
at serine 473 to regulate cell survival and nutrient uptake [17–19]. mTORC1, but not mTORC2,
is sensitive to acute rapamycin treatment. Recent studies have found that mTOR and its tight reg-
ulation play important roles in innate immune responses [11, 15, 16, 20–22]. Many extracellular
signals induce mTORC1 and mTORC2 activation in innate immune cells, including TLR, cyto-
kines, and growth factors [15, 20, 23]. mTORC1controls macrophage polarization [12, 21], is
important for alveolar macrophage self-renewal [24], and regulates dendritic cell metabolism,
maturation, and function [25–27]. Whether V. vulnificus can induce mTOR activation and how
mTOR may regulate innate immune responses to this pathogen in macrophages is unknown.
In this report, we demonstrated that V. vulnificus could directly inflict liver damage and
induce strong innate immune responses and Kupffer cell expansion. Moreover, V. vulnificus
can activate mTOR in macrophages and inhibition of mTOR differentially regulates V. vulnifi-
cus induced inflammatory responses.
Results
Acute infection by V. vulnificus CGMCC1.1758 strain induced liver
inflammation in C57BL/6J mice
Patients with liver diseases are susceptible to severe V. vulnificus infection. One of the liver’s
key functions is to clear blood-borne pathogens and to prevent bacteria from spreading to
other organs to cause sepsis [28]. Several strains of V. vulnificus have been found to cause sys-
temic infection in mice [29–31]. However, whether the V. vulnificus 1.1758 strain can cause
liver damage has been unclear. To examine whether V. vulnificus is capable of causing liver
damage, we intraperitoneally (i.p.) injected V. vulnificus CGMCC1.1758 into wild-type
C57BL/6J mice. Mice injected with 1×108 CFU V. vulnificus showed higher mortality than
those injected with 5×107 CFU (Fig 1A). V. vulnificus infection resulted in liver damage, indi-
cated by elevated serum alanine aminotransferase (ALT) and aspartate aminotransferase
(AST) levels (Fig 1B). H&E staining showed piecemeal necrosis, focal inflammation, and portal
inflammation in the liver (Fig 1C and 1D). Additionally, we detected V. vulnificus in liver
homogenates (Fig 1E). These observations indicated that V. vulnificus CGMCC1.1758 is capa-
ble of inducing liver inflammatory damage in wild-type C57BL/6J mice.
V. vulnificus acute infection-induced Kupffer cell and neutrophil
accumulation in the liver
To determine the infiltrating cell types in the liver after V. vulnificus infection, we performed
immunofluorescence analysis of frozen liver sections of V. vulnificus-infected and control mice.
As Fig 2A and 2B shows, both CD68+CD11b+ Kupffer cells and CD11b+Ly6G+ neutrophils
accumulated in the livers of infected mice. To further confirm Kupffer cell accumulation, we
performed FACS analysis of liver mononuclear cells. As shown in Fig 2C and 2D, CD11b+F4/
80int Kupffer cells were considerably increased in V. vulnificus infected mice. Thus, acute V. vul-
nificus infection caused Kupffer cell accumulation in the liver.
V. vulnificus acute infection-induced Kupffer cell proliferation and
proinflammatory responses in vivo
To determine whether Kupffer cell accumulation in the liver after V. vulnificus infection was
associated with increased proliferation, we injected BrdU into mice immediately before V. vul-
nificus infection. Six hours after injection, Kupffer cells from V. vulnificus-infected livers
mTOR in Vibrio vulnificus induced inflammatory responses
PLOS ONE | https://doi.org/10.1371/journal.pone.0181454 July 18, 2017 2 / 13
0fe0f_WYMDZFIQCqNw1c9XPFZHx2ZqWbfK-
vMyYmDag&e=), Zhejiang Provincial Natural
Science Foundation Grant (LY13H190007 to DLX,
https://urldefense.proofpoint.com/v2/url?u=http-
3A__www.zjnsf.gov.cn_&d=DwIFAw&c=
imBPVzF25OnBgGmVOlcsiEgHoG1i6YHLR0Sj_
gZ4adc&r=S_JYpfDmLaCC5h9z1VAJNljLauCLn5
g6DAXa1EehYb0&m=XlUXuJN_RGJRbtSLmM3
3ECqPzzZvZGaLjTSBWV1zNYk&s=K2ZgERc
PVNiUyndwY4LhAspigWjqM5RyMwy_scnu
4bU&e=), Zhejiang Provincial Medical Science
Foundation Grant (2015KYB238 to YZ, https://
urldefense.proofpoint.com/v2/url?u=http-3A__kj.
zjwst.gov.cn_&d=DwIFAw&c=imBPVzF25OnBgGm
VOlcsiEgHoG1i6YHLR0Sj_gZ4adc&r=S_JYpfDm
LaCC5h9z1VAJNljLauCLn5g6DAXa1EehYb0&m=
XlUXuJN_RGJRbtSLmM33ECqPzzZvZGaLjTSB
WV1zNYk&s=WB6AuX6_w2TICh2hnlf24l30E1HS
GfAGSdWd7RhEH1k&e=) and Open Fund of
Zhejiang Provincial Top Key Discipline of Clinical
Medicine (Laboratory Medicine, to XFY, https://
urldefense.proofpoint.com/v2/url?u=http-3A__
www.wmu.edu.cn_view.php-3Fid-3D77e70089-
2D5da6-2D11e5-2Dbc3f-2Dddc6031fe976&d=
DwIFAw&c=imBPVzF25OnBgGmVOlcsiEgHoG1
i6YHLR0Sj_gZ4adc&r=S_JYpfDmLaCC5h9z1VAJ
NljLauCLn5g6DAXa1EehYb0&m=XlUXuJN_
RGJRbtSLmM33ECqPzzZvZGaLjTSBWV1zNYk&s=
6-arDcNi5NqGgPiXmJmMElAc45P0zwrK9BLP7u
FI-DY&e=), and The National Institute of Allergy
and Infectious Diseases-R01 (AI101206 to XPZ,
https://urldefense.proofpoint.com/v2/url?u=https-
3A__projectreporter.nih.gov_project-5Finfo-5F
details.cfm-3Faid-3D9062374-26icde-3D349
92657&d=DwIFAw&c=imBPVzF25OnBgGmVOlc
siEgHoG1i6YHLR0Sj_gZ4adc&r=S_JYpfDmLa
CC5h9z1VAJNljLauCLn5g6DAXa1EehYb0&m=
XlUXuJN_RGJRbtSLmM33ECqPzzZvZGaLjT
SBWV1zNYk&s=r9ZA99LrG01jRVyy7Sk6U
wMXa7gVQa0zENQuubK4QGE&e=). The funders
did not play a role in experimental design.
Competing interests: The authors have declared
that no competing interests exist.
incorporated more BrdU than those in uninfected mice, suggesting that these cells proliferated
in infected mice (Fig 3A). Kupffer cells from V. vulnificus-infected mice upregulated CD71
(transferrin receptor protein 1, required for iron delivery from transferrin to cells) and CD98
(an amino acid transporter) (Fig 3B). In vitro, V. vulnificus infection of BMMϕs also upregu-
lated CD71 and CD98 (Fig 3C), suggesting that V. vulnificus directly acted on macrophages to
induce expression of these molecules. Elevated expression of CD71 and CD98 might ensure
sufficient nutrients for macrophage metabolism, proliferation, and function. Together, these
Fig 1. Induction of liver inflammation by V. vulnificus CGMCC1.1758 strain acute infection. (A) Survival curves for 5–6-week-old
C57BL/6J mice by i.p. injection of 5 × 107 CFU or 1 × 108 CFU of V. vulnificus (CGMCC1.1758 strain). P<0.01 between uninfected group
and 1 × 108 CFU group assessed with the log-rank survival analysis (n = 10 in each group). (B) Serum AST and ALT concentrations in
uninfected and 1 × 108 CFU V. vulnificus-infected mice 6 hours after infection. The values are the means ± SEM of at least triplicate
samples (n = 4). *, P<0.05 determined by Student’s t-test. (C) H&E stain of liver thin sections from control and 1 × 108 CFU of V. vulnificus
group 6 hours after injection. (D) Ishak score of liver inflammation in V. vulnificus-infected mice. The scores of all control mice were zero,
and were not shown. (E) Detection of V. vulnificus after overnight culture of liver homogenates in BHI rabbit blood plates. We prepared liver
homogenates 6 hours after 1 × 108 CFU V. vulnificus infection. Data shown are representative of at least three experiments.
https://doi.org/10.1371/journal.pone.0181454.g001
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observations suggest that acute V. vulnificus infection caused Kupffer cells to accumulate in
the liver by inducing their proliferation.
To determine if V. vulnificus induced inflammatory responses, we measured cytokines con-
centrations in the serum and liver homogenates after V. vulnificus infection using a multiplex
flow assay. In V. vulnificus-infected mice, multiple cytokines, such as IL-27, IL-6, IL-10, and
MCP-1, obviously increased in both blood and liver (Fig 3D). Several other cytokines, such as
IFN-β, IL-23, IL-12 p40, and IL-1α, increased only in the liver, while TNF-αwas increased in
serum, but not in the liver. The differences between liver and blood could result from differ-
ences in bacterial burdens and in local immune cell compositions in these organs/tissues.
Thus, V. vulnificus infection triggered strong innate immune responses in vivo.
Activation of NFκB and mTOR in macrophages by V. vulnificus
Transcription of many cytokines depends on NFκB after stimulating pathogen pattern recog-
nition receptors [5, 32]. Bone marrow derived macrophages (BMMϕs) infected with live 0.2
MOI V. vulnificus or treated with heat inactivated V. vulnificus (In) or V. vulnificus lysates for 6
hours contained increased IKKα/β and IκBα phosphorylation (Fig 4A), suggesting that V. vul-
nificus was capable of triggering IKK-NFκB activation. Low dose (0.2 MOI) V. vulnificus
Fig 2. Accumulation of Kupffer cells and neutrophils in the liver after acute V. vulnificus infection. We injected C57BL/6J mice with PBS or
1 × 108 CFU of V. vulnificus. Six hours later, we harvested livers for analysis. (A) Confocal microscopy detection of Kupffer cells (CD68+CD11b+) and
neutrophils (Ly6G+CD11b+) in frozen liver sections (magnification: 400×). (B) Bar figures show mean ±SEM of numbers of indicated cells in 4 fields from
V. vulnificus-infected mice (n = 4). Cell count was analyzed by Nikon NIS Elements software with General Analysis Plug. (C) Representative dot plots
showing F4/80 and CD11b staining in liver mononuclear cell preparations. (D) Bar graphs show the frequency of CD11bintF4/80+ liver macrophages
subsets. The values are the means ±SEM (n = 6). Data shown are representative of at least three experiments. ***, P<0.001 as determined by
Student’s t-test.
https://doi.org/10.1371/journal.pone.0181454.g002
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treatment also induced phosphorylation of mTOR, S6K1, S6, 4EBP1 and Akt. However, 2
MOI of V. vulnificus-treated cells did not induce phosphorylation of these proteins (Fig 4A),
which was likely caused by negative feedback mechanisms triggered by over-stimulation or by
death of BMMϕs after 6 hours of infection. Indeed, after 3 hours treatment, 2 MOI V. vulnifi-
cus induced stronger S6K1 and S6 phosphorylation than 0.2 MOI V. vulnificus (Fig 4B). More-
over, Kupffer cells from V. vulnificus-infected mice also contained increased 4E-BP1 and Akt
S473 phosphorylation (Fig 4C). These observations suggested that V. vulnificus induced both
mTORC1 and mTORC2 activation in macrophages in vitro and in vivo.
To examine if V. vulnificus could directly induce innate immune responses in macrophages,
we treated BMMϕs with live V. vulnificus or heat inactivated V. vulnificus, or V. vulnificus cul-
ture supernatant (Sup) in vitro for 6 hours. As Fig 4D shows, both live and heat-inactivated V.
vulnificus induced IL-6, IL-10, TNF-α, and IL-1α production in these cells. In addition, live
but not inactivated V. vulnificus induced GM-CSF, IFNβ, IL-27, and IL-1β production. Inter-
estingly, treatment of BMMϕs with rapamycin during V. vulnificus stimulation resulted in
Fig 3. Increased Kupffer cell proliferation and proinflammatory cytokines production after acute V. vulnificus infection.
We injected BrdU into C57BL/6J mice and then with PBS or 1 × 108 CFU of V. vulnificus. Six hours later, we harvested livers for
analysis. (A) The contour plot and bar graph show the frequency of BrdU-incorporated CD11bintF4/80+ liver macrophages (n = 3).
(B) CD71 and CD98 expression on CD11bintF4/80+ macrophages. (C) CD71 and CD98 expression in live CD11b+F4/80+ BMMϕs
after 6 hours in vitro V. vulnificus infection. (D) Cytokine expression profile in serum and liver homogenates from 1 × 108 CFU V.
vulnificus-infected mice and control mice 6 hours after infection measured by the multiplex flow assay (Biolegend). The values are
the means ± SEM (n = 3). Data shown are representative of at least three experiments. **, P<0.01 as determined by Student’s t-
test.
https://doi.org/10.1371/journal.pone.0181454.g003
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Fig 4. Effects of V. vulnificus inducted mTOR activation on innate immune responses in macrophages. (A)
Detection of protein phosphorylation in BMMϕ treated with live or heat-inactivated V. vulnificus, its lysates, or culture
mTOR in Vibrio vulnificus induced inflammatory responses
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decreased expression of GM-CSF, IFNβ, IL-27, and MCP-1 without obviously affecting the
production of other cytokines. In rapamycin treated BMMϕs, V. vulnificus-induced S6K1 and
S6 phosphorylation was abolished and Akt phosphorylation was deminished (Fig 4E), consis-
tent with the notion that rapamycin is able to inhibit not only mTORC1 but also mTORC2.
Interestingly, V. vulnificus CFUs were lower in rapamycin treated BMMϕ compared with
untreated controls (Fig 4F), which could also contribute to decreased expression of cytokines
induced after treatment with rapamycin. Together, these observations suggested that V. vulni-
ficus contain heat resistant and labile components that can induce multiple cytokine produc-
tion in macrophages and that mTOR is important for V. vulnificus proliferation in BMMϕs
and may selectively regulate expression of certain but not all cytokines induced by V.
vulnificus.
Discussion
V. vulnificus infection causes sepsis in the host and induces inflammation via recruiting and
activating immune cells such as neutrophils, monocytes, and macrophages. Extensive work
has linked various virulence factors of V. vulnificus to cell death and modulation of innate
immune responses to this pathogen [30, 33–37]. Patients with liver diseases such as cirrhosis
are more susceptible to developing V. vulnificus infection, which can lead to sepsis, sepsis-
induced organ failure, and even death [38]. Surprisingly, little is known about the liver phase
during V. vulnificus infection. In this report, we showed that V. vulnificus CGMCC1.1758 was
capable of inducing inflammatory responses in the liver and inflicting liver damage in C57BL/
6J mice, manifested by induction of multiple inflammatory cytokines and elevated serum AST
and ALT levels. These observations are consistent with a previous report that another V. vulni-
ficus strain, M06-24/O, is capable of causing liver inflammation and damage in BALB/c mice
[31].
As tissue-resident macrophages, Kupffer cells are strategically located to clear bacteria in
the liver during infection. Kupffer cells do not obviously proliferate in the steady state [39].
We have found that Kupffer cell numbers drastically increased in mice after V. vulnificus
CGMCC1.1758 infection, which is at least partially caused by proliferation. Like V. vulnificus
infection, systemic Listeria monocytogenes infection also results in Kupffer cell proliferation
[40]. Thus, Kupffer cell expansion after bacterial infection may represent a means to increase
the capacity of tissue-resident macrophages for clearance of invading pathogens. In addition to
proliferation, V. vulnificus infection could increase Kupffer cells via other mechanisms. Our
study provides the first evidence that V. vulnificus can cause mTOR activation. In BMMϕ, either
infection with live V. vulnificus or treatment with heat-inactivated V. vulnificus or V. vulnificus
lysates induces mTORC1 and mTORC2 activation reflected by 4EBP1 and Akt S473 phosphory-
lation, respectively. Thus, V. vulnificus contains component(s) that can induce mTOR activation,
although these components and the pattern recognition receptors that lead to mTOR activation
remain to be identified. As mentioned earlier, mTOR and its tight regulation play important
roles in innate immune responses [11, 15, 16, 20–22]. We have found that V. vulnificus infection
supernatant for 6 hours. (B) Detection of protein phosphorylation in BMMϕ treated with 0.2 or 2.0 MOI V. vulnificus for 3h.
(C) Detection of 4E-BP1 (Thr37/46) and Akt (Ser473) phosphorylation by intracellular staining and FACS analysis in
CD11bintF4/80+cells isolated from liver of after infection of mice with 1 × 108 CFU V. vulnificus (n = 3). Means ± SEM in
the plots show MFI of 4E-BP1 (Thr37/46) and Akt (Ser473) phosphorylation. (D) Cytokine profile in the supernatants of
BMMϕ after in vitro V. vulnificus infection for six hours in the presence or absence of 100 nM rapamycin. (E) Detection of
protein phosphorylation in BMMϕ treated by 0.2 MOI V. vulnificus for 6h in the presence or absence of 100nM rapamycin.
(F) Growth-curve of V. vulnificus in the supernatant of BMMϕs infected with 0.2 MOI V. vulnificusin the presence or
absence of 100nM. Data shown represent three experiments.
https://doi.org/10.1371/journal.pone.0181454.g004
mTOR in Vibrio vulnificus induced inflammatory responses
PLOS ONE | https://doi.org/10.1371/journal.pone.0181454 July 18, 2017 7 / 13
triggered strong inflammatory responses in vivo and V. vulnificus treatment induced production
of multiple cytokines in macrophages. Among these cytokines, GM-CSF, IFNβ, IL-27, and IL-1β
production but not IL-6, IL-10, TNF-α, and IL-1α production is dependent on mTOR activity.
It would be interesting to further determine the underlying mechanisms by which mTOR con-
trols production of selective cytokines during V. vulnificus infection.
Materials and methods
Ethics statement
This study was carried out in strict accordance with the guidelines of the Zhejiang Provincial
Animal Care and Use Administration Office (SYXK-ZJ-2005-0061). We performed all the ani-
mal experiments in accordance with protocols approved by the Wenzhou Medical University
Animal Care and Use Committee (reference: wydw2014-0009).
Bacterial strains, mice and cell culture
We purchased C57BL/6J mice from Wenzhou Medical University Laboratory Animal Facility
and were maintained under a SPF environment at the Central Animal Laboratory of Wenzhou
Medical University. The mice were kept for 5–7 days to acclimatize after transport from the
supplier. In the survival experiment, mice were observed every 30 minutes for 24 hours, and
mice that survived for 24 hours were euthanized. L-929 cells were purchased from the Cell
Bank of the Chinese Academy of Science in Shanghai and cultured them in RPMI1640 con-
taining 10% heat-inactivated fetal bovine serum (Ausvin) and penicillin-streptomycin (50 IU/
ml and 50 mg/ml; Beyotime). The China General Microbiological Culture Collection Center
provided the Vibiro vulnificus CGMCC 1.1758 strain, which we grew at 37˚C in brain heart
infusion broth (BHI) or on the BHI rabbit blood agar plate.
In vivo infection
We used i.p. injection to infect female C57BL/6J mice with V. vulnificus. For survival experi-
ments, we i.p. injected mice with 5×107 or 1×108 CFU of V. vulnificus suspended in 200 μl
PBS or with PBS alone. We euthanized and exsanguinated the mice 6 hours after infection for
blood and tissue collection. The liver was fixed it in 4% paraformaldehyde for histological anal-
ysis, and froze it in OCT medium (Thermo) for immunofluorescence analysis. To measure V.
vulnificus CFU in the liver, we perfused infected mice with PBS before harvesting their livers.
We cultured liver homogenate on BHI blood agar plates at 37˚C for 24 hours. We measured
serum AST and ALT levels using AST and ALT kits (NjjcBio) following the manufacturer’s
protocol.
Bacterial treatment of BMMϕs in vitro and Western blot
We isolated bone marrow cells and cultured them with 10% L-929 cell culture medium as
described previously [15]. We plated BMMϕs in 35 mm dishes and cultured them for 12
hours. We then added live or heat inactivated V. vulnificus at the indicated multiplicity of
infection (MOI) or V. vulnificus lysates to the cells. We collected supernatants at the indicated
times for cytokine quantification. We then subjected the infected cells to lysate preparation
and Western blot analysis by following a previous protocol [41]. Anti-phosho-mTOR, anti-
phosho-S6K1, anti-phosho-S6, anti-phosho-Akt, anti-phosho-4EBP1, anti-phosho-IKKα/β,
anti-phosho-IκBα, and anti-β actin antibodies all came from Cell Signaling Technology.
mTOR in Vibrio vulnificus induced inflammatory responses
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Measurement of cytokines by multiplex flow assay
We measured multi-cytokines by using a LEGENDplex multi-analyte flow assay kit (13-plex)
for mouse inflammation panel (Biolegend). We assessed the cytokine concentrations in sera,
liver homogenates, and supernatants of cultured cells according to the manufacturer’s instruc-
tions. We collected data using a BD FACSAria II and analyzed them with LEGENDplex data
analysis software (Biolegend).
BrdU incorporation
We intraperitoneally injected the mice with 1 mg BrdU (BD Bioscience) in 200 μl PBS, then
with1×108 CFU of V. vulnificus two hours later. We harvested the liver from each infected
mouse six hours after infection, isolating liver monocytes by following the previous protocol
[42]. Briefly, livers were mashed in IMDM with 10% FBS. The upper cell suspension was fil-
tered by nylon mesh and spun at 4˚C, 2000 rpm for 5 min. The cell pellet was resuspended in
12 ml 35% Percoll (GE Healthcare), and carefully underlaid with an equal volume of 75% Per-
coll, and centrifuged at 1000 × g for 20 min at room temperature without break. Cells at the
interface were collected, washed and resupended in IMDM (10% FBS) for further staining. We
stained the cell surface with CD11b and F4/80 (Biolegend) and used a BrdU Flow Kit (BD Bio-
science) for BrdU intracellular staining, following the manufacturer’s protocol.
Flow cytometry
We performed cell surface staining with fluorescence-conjugated antibodies in 2% FBS–PBS.
We obtained fluorochrome-conjugated anti-CD11b, anti-F4/80, anti-CD71, and anti-CD98
from Biolegend. We identified cell death using a violet Live/Dead kit (Invitrogen). We per-
formed intracellular staining for Alexa Fluor 647-conjugated p-Akt (Ser473) and p-4EBP1
(Thr37/46) (Cell Signaling Technology) using BD Biosciences Cytofix/Cytoperm and Perm/
Wash solutions. We collected data using a BD FACSAria II and analyzed them with FlowJo
(Treestar).
Histological and immunofluorescence analysis
For histology analysis, we imbedded the fixed livers in paraffin, then cut thin sections, and fol-
lowing standard procedures, stained them with hematoxylin and eosin. We quantified the liver
histological score of inflammation according to Ishak inflammation score [43, 44]. For immuno-
fluorescence analysis, we cut frozen sections into 8μM slices in a cryostat microtome (Thermo)
at -20˚C and permeabilized and blocked them. We probed the tissues with appropriate, fluores-
cently labelled antibodies, including APC-conjugated anti-CD11b, PE-conjugated anti-CD68,
and PE-conjugated anti-Ly6G (Biolegend). Finally, we dried the sections and observed them
with a Nikon A1 confocal microscope.
Statistical analysis
We analyzed statistical significance using the Student t test and determined survival difference
by log-rank survival analysis, performing all statistics using Graphpad Prism 5.0 software. P
values are defined as follows: P< 0.05, P< 0.01, and P< 0.001.
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